Inactive Instrument

Highlights FS Development Corp.

Equities

Gemini Therapeutics, Inc. completed the acquisition of FS Development Corp. in a reverse merger transaction.	04/02/21	CI
Gemini Therapeutics, Inc. entered into a definitive merger agreement to acquire FS Development Corp. for approximately $240 million in a reverse merger transaction.	14/10/20	CI
FS Development Corp. Announces Board Appointments	14/08/20	CI
FS Development Corp. has completed an IPO in the amount of $105 million.	11/08/20	CI
FS Development Corp. has filed an IPO in the amount of $100 million.	24/07/20	CI

No results for this search